Improved chemical synthesis and demonstration of the relaxin receptor binding affinity and biological activity of mouse relaxin

Biochemistry

Volumn 46, Issue 18, 2007, Pages 5374-5381

  Samuel, Chrishan S ^a   Lin, Feng ^a   Hossain, Mohammed Akhter ^a   Zhao, Chongxin ^a   Ferraro, Tania ^a   Bathgate, Ross A D ^a   Tregear, Geoffrey W ^a   Wade, John D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; BINDING ENERGY; BIOLOGICAL ORGANS; COLLAGEN; MAMMALS; SYNTHESIS (CHEMICAL);

COLLAGEN DEPOSITION; RELAXIN RECEPTOR; RODENTS;

GENETIC ENGINEERING;

RELAXIN;

ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BETA CHAIN; BINDING AFFINITY; BIOACCUMULATION; BIOLOGICAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE COURSE; DISULFIDE BOND; FIBROSIS; HISTOLOGY; HORMONE ACTION; HORMONE BINDING; HORMONE BLOOD LEVEL; HORMONE RECEPTOR INTERACTION; HORMONE SYNTHESIS; KIDNEY FIBROSIS; LONG TERM EXPOSURE; LUNG FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CULTURE; SKIN FIBROSIS; STATISTICAL SIGNIFICANCE; TESTIS; TREATMENT DURATION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CELL LINE; FIBROSIS; HUMANS; KIDNEY CORTEX; LUNG; MALE; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PEPTIDE BIOSYNTHESIS; PROTEIN BINDING; RATS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RELAXIN; SKIN; TESTIS;

MURINAE; MUS; RATTUS; RODENTIA;

EID: 34248209667     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi700238h     Document Type: Article

References (37)

1. Hisaw, F. (1926) Experimental relaxation of the pubic ligament of the guinea pig, Proc. Soc. Exp. Biol. Med. 23, 661-663.
2. Schwabe, C., and McDonald, J. K. (1977) Relaxin: a disulfide homolog of insulin, Science 197, 914-915.
3. Bathgate, R. A. D., Hsueh, A. J., and Sherwood, O. D. (2006) Physiology and molecular biology of the relaxin peptide family, in Physiology of Reproduction (Knobil, E., and Neill, J.D. Eds.) 3rd ed., pp 679-770, Elsevier, San Diego, CA.
4. Sherwood, O. D. (2004) Relaxin's physiological roles and other diverse actions, Endocr. Rev. 25, 205-234.
5. Samuel, C. S., Du, X. J., Bathgate, R. A. D., and Summers, R. J. (2006) "Relaxin" the stiffened heart and arteries: The therapeutic potential for relaxin in the treatment of cardiovascular disease, Pharmacol. Ther. 112, 529-552.
6. Perna, A. M., Masini, E., Nistri, S., Briganti, V., Chiappini, L., Stefano, P., Bigazzi, M., Pieroni, C., Bani, Sacchi, T., and Bani, D. (2005) Novel drug development opportunity for relaxin in acute myocardial infarction: evidences from a swine model, FASEB J. 19, 1525-1527.
7. McKinley, M. J., Cairns, M. J., Denton, D. A., Egan, G., Mathai, M. L., Uschakov, A., Wade, J. D., Weisinger, R. S., and Oldfield, B. J. (2004) Physiological and pathophysiological influences on thirst, Physiol. Behav. 81, 795-803.
8. Nistri, S., and Bani, D. (2005) Relaxin in vascular physiology and pathophysiology: possible implications in ischemic brain disease, Curr. Neurovasc. Res. 2, 225-233.
9. Samuel, C. S. (2005) Relaxin: antifibrotic properties and effects in models of disease, Clin. Med. Res. 3, 241-249.
10. Hsu, S. Y., Nakabayashi, K., Nishi, S., Kumagai, J., Kudo, M., Sherwood, O. D., and Hsueh, A. J. (2002) Activation of orphan receptors by the hormone relaxin, Science 295, 671-674.
11. Bathgate, R. A., Ivell, R., Sanborn, B. M., Sherwood, O. D., and Summers, R. J. (2006) International Union of Pharmacology: Recommendations for the nomenclature of receptors for relaxin family peptides, Pharmacol. Rev. 58, 7-31.
12. Hudson, P., Haley, J., John, M., Cronk, M., Crawford, R., Haralambidis, J., Tregear, G., Shine, J., and Niall, H. (1983) Structure of a genomic clone encoding biologically active human relaxin, Nature 301, 628-631.
13. Hudson, P., John, M., Crawford, R., Haralambidis, J., Scanlon, D., Gorman, J., Tregear, G., Shine, J., and Niall, H. (1984) Relaxin gene expression in human ovaries and the predicted structure of a human preprorelaxin by analysis of cDNA clones, EMBO J. 3, 2333-2339.
14. Bathgate, R. A., Samuel, C. S., Burazin, T. C., Layfield, S., Claasz, A. A., Reytomas, I. G., Dawson, N. F., Zhao, C., Bond, C., Summers, R. J., Parry, L. J., Wade, J. D., and Tregear, G. W. (2002) Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene. Novel members of the relaxin peptide family, J. Biol. Chem. 277, 1148-1157.
15. Evans, B. A., John, M., Fowler, K. J., Summers, R. J., Cronk, M., Shine, J., and Tregear, G. W. (1993) The mouse relaxin gene: nucleotide sequence and expression, J. Mol. Endocrinol. 10, 15-23.
16. Bathgate, R. A. D., Lin, F., Hanson, N. F., Otvos, L., Jr., Guidolin, A., Giannakis, C., Bastiras, S., Layfield, S. L., Ferraro, T., Ma, S., Zhao, C., Gundlach, A. L., Samuel, C. S., Tregear, G. W., and Wade, J. D. (2006) Relaxin-3: Improved synthesis strategy and demonstration of its high affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo, Biochemistry 45, 1043-1053.
17. Samuel, C. S., Zhao, C., Bathgate, R. A., Bond, C. P., Burton, M. D., Parry, L. J., Summers, R. J., Tang, M. L. K., Amento, E. P., and Tregear, G. W. (2003) Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis, FASEB J. 17, 121-123.
18. Garber, S. L., Mirochnik, Y., Brecklin, C. S., Unemori, E. N., Singh, A. K., Slobodskoy, L., Grove, B. H., Arruda, J. A., and Dunea, G. (2001) Relaxin decreases renal interstitial fibrosis and slows progression of renal disease, Kidney Int. 59, 876-882.
19. Bullesbach, E. E., and Schwabe, C. (1993) Mouse relaxin: synthesis and biological activity of the first relaxin with an unusual crosslinking pattern, Biochem. Biophys. Res. Commun. 196, 311-319.
20. Rosengren, K. J., Zhang, S., Lin, F., Daly, N. L., Scott, D. J., Hughes, R. A., Bathgate, R. A., Craik, D. J., and Wade, J. D. (2006) Solution structure and characterization of the LGR8 receptor binding surface of insulin-like peptide 3, J. Biol. Chem. 281, 28287-28295.
21. Hossain, M. A., Zhang, S., Lin, F., Ferraro, T., Bathgate, R. A., Tregear, G. W., and Wade, J. D. (2006) Regioselective disulfide solid phase synthesis, chemical characterization and in vitro receptor binding activity of equine relaxin, Int. J. Pept. Res. Ther. 12, 211-215.
22. Samuel, C. S., Zhao, C., Bathgate, R. A., Du, X. J., Summers, R. J., Amento, E. P., Walker, L. L., McBurnie, M., Zhao, L., and Tregear, G. W. (2005) The relaxin gene-knockout mouse: a model of progressive fibrosis, Ann. N.Y. Acad. Sci. 1041, 173-181.
23. Maruyama, K., Nagasawa, H., and Suzuki, A. (1999) 2,2′-Bispyridyl disulfide rapidly induces intramolecular disulfide bonds in peptides, Peptides 20, 881-884.
24. Halls, M. L., Bond, C. P., Sudo, S., Kumagai, J., Ferraro, T., Layfield, S. L., Bathgate, R. A., and Summers, R. J. (2005) Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8), J. Pharmacol. Exp. Ther. 313, 677-687.
25. Scott, D. J., Layfield, S., Riesewijk, A., Morita, H., Tregear, G. W., and Bathgate, R. A. (2005) Characterization of the mouse and rat relaxin receptors, Ann. N.Y. Acad Sci. 1041, 8-12.
26. Samuel, C. S., Unemori, E. N., Mookerjee, I., Bathgate, R. A., Layfield, S. L., Mak, J., Tregear, G. W., and Du, X. J. (2004) Relaxin modulates cardiac fibroblast proliferation, differentiation and collagen production and reverses cardiac fibrosis in vivo, Endocrinology 145, 4125-4133.
27. Zhao, L., Roche, P. J., Gunnersen, J. M., Hammond, V. E., Tregear, G. W., Wintour, E. M., and Beck, F. (1999) Mice without a functional relaxin gene are unable to deliver milk to their pups, Endocrinology 140, 445-453.
28. Du, X. J., Samuel, C. S., Gao, X. M., Zhao, L., Parry, L. J., and Tregear, G. W. (2003) Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype, Cardiovasc. Res. 57, 395-404.
29. Samuel, C. S., Zhao, C., Bond, C. P., Hewitson, T. D., Amento, E. P., and Summers, R. J. (2004) Relaxin-1-deficient mice develop an age-related progression of renal fibrosis, Kidney Int. 65, 2054-2064.
30. Samuel, C. S., Zhao, C., Yang, Q., Wang, H., Tian, H., Tregear, G. W., and Amento, E. P. (2005) The relaxin gene knockout mouse: a model of progressive scleroderma, J. Invest. Dermatol. 125, 692-699.
31. Samuel, C. S., Tian, H., Zhao, L., and Amento, E. P. (2003) Relaxin is a key mediator of prostate growth and male reproductive tract development, Lab. Invest. 83, 1055-1067.
32. Bergman, I., and Loxley, R. (1963) Two improved and simplified methods for the spectrophotometric determination of hydroxyproline, Anal. Chem. 35, 1961-1965.
33. Zhang, J., Qi, Y. F., Geng, B., Pan, C. S., Zhao, J., Chen, L., Yang, J., Chang, J. K., and Tang, C. S. (2005) Effect of relaxin on myocardial ischemia injury induced by isoproterenol, Peptides 26, 1632-1639.
34. Unemori, E. N., Pickford, L. B., Salles, A. L., Piercy, C. E., Grove, B. H., Erikson, M. E., and Amento, E. P. (1996) Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo, J. Clin. Invest. 98, 2739-2745.
35. Williams, E. J., Benyon, R. C., Trim, N., Hadwin, R., Grove, B. H., Arthur, M. J., Unemori, E. N., and Iredale, J. P. (2001) Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo, Gut 49, 577-583.
36. Lekgabe, E. D., Kiriazis, H., Zhao, C., Xu, Q., Moore, X.-L., Su, Y., Bathgate, R. A. D., Du, X.-J., and Samuel, C. S. (2005) Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats, Hypertension 46, 412-418.
37. Scott, D. J., Fu, P., Shen, P. J., Gundlach, A. L., Layfield, S., Riesewijk, A., Tomiyama, H., Hutson, J. M., Tregear, G. W., and Bathgate, R. A. (2005) Characterization of the rat INSL3 receptor, Ann. N.Y. Acad. Sci. 1041, 13-16.